Show simple item record

dc.contributor.advisorHutt, Peter Bartonen_US
dc.contributor.authorCarson, Cheryl J.en_US
dc.date.accessioned2012-07-06T21:28:33Z
dc.date.issued1997en_US
dc.identifier.citationThe Effect of Managed Care on the Pharmaceutical Industry (1997 Third Year Paper)en
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:8965565
dc.description.abstractThe pharmaceutical industry has transformed itself in response to the growth of managed care, which developed as a method to contain the costs of health care. Under the traditional fee-for-service system of practicing medicine, doctors practiced medicine without incentives to reduce the costs imposed on patients, their insurers, and the health care system. Most doctors practiced independently and were reimbursed for each service rendered by passive insurance companies. Shielded from the oversight of third-party intermediaries, doctors had financial incentives to provide more services, regardless of whether those services were therapeutically necessary.en
dc.language.isoen_USen
dash.licenseLAAen_US
dc.subjectFood and Drug Lawen
dc.subjectmanaged careen
dc.subjecthuman drugsen
dc.subjectpharmaceutical industryen
dc.titleThe Effect of Managed Care on the Pharmaceutical Industryen
dc.typePaper (for course/seminar/workshop)en_US
dc.date.available2012-07-06T21:28:33Z
dash.authorsorderedfalse


Files in this item

Thumbnail
Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record